The Biotime BNP Rapid Quantitative Test is designed for the auxiliary diagnosis of heart failure by measuring the concentration of B-type Natriuretic Peptide (BNP) in human blood samples. BNP is secreted by the ventricles in response to increased cardiac wall stress, volume overload, or pressure, making it a critical biomarker for assessing cardiac function.

The test is highly sensitive and specific, offering clinicians reliable data to distinguish cardiac from non-cardiac causes of dyspnea. As BNP levels correlate with ventricular strain, the test serves as a valuable tool for both diagnosis and prognosis in acute and chronic heart failure cases.

Requiring only a small blood sample, this assay delivers quantitative results in just 10 minutes and can be performed at the point of care without the need for refrigerated storage.